Skip to main content

Elemar Piros

Analyst

Lucid Capital Markets

Equibles does not estimate personal net worth.

About Elemar Piros

Elemar Piros is recorded as Analyst at Lucid Capital Markets. Elemar Piros has spoken on 1 earnings call across 1 company, most recently for NRX Pharmaceuticals, Inc. on November 17, 2026. The companies whose calls Elemar Piros spoke on are classified in the Healthcare sector.

Elemar Piros on recent calls

“The preservative-free ketamine, which you used to call kata-free, does that have a name, a new name, or you stay with kata-free?”
Analyst — Lucid Capital Markets, Q3 2026 Financial Results Conference Call ·

Affiliation history

  • Lucid Capital Markets

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity